Vivet Therapeutics
Paris
About Vivet Therapeutics
Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through a partnership with the Fundacion para la Investigacion Medica Aplicada (FIMA) at the Centro de Investigación Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $97.9M
- Last round: Grant (Feb 2024)
- Website: vivet-therapeutics.com
- Phone: +33684755087
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/vivet-therapeutics-8480 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.